Thi Thu Thao Nguyen

Title: Innovations of Thi Thu Thao Nguyen in Ocular Drug Delivery

Introduction

Thi Thu Thao Nguyen is an accomplished inventor based in Suwon-si, South Korea. She has made significant contributions to the field of ocular drug delivery through her innovative research and development. Her work focuses on enhancing the effectiveness of eye drops using advanced nanoparticle technology.

Latest Patents

Thi Thu Thao Nguyen holds a patent for "Eye drops containing chitosan nanoparticles in which PDRN is encapsulated, and preparation method therefor." This invention relates to nucleic acid fragment-encapsulated polymer nanoparticles and a method of preparing them. The polymer used is a mucoadhesive polymer, specifically chitosan, while the nucleic acid fragment is polydeoxyribonucleotide (PDRN). These nanoparticles can be utilized as eye drops, adhering to the ocular mucous membrane and allowing for the slow release of nucleic acid fragments. This innovative approach increases patient convenience and reduces costs by maintaining high efficiency even with a small drug dosage.

Career Highlights

Thi Thu Thao Nguyen is currently associated with Zerone Bio Inc., where she continues to advance her research in the field of drug delivery systems. Her work has garnered attention for its potential to improve therapeutic outcomes in ocular treatments.

Collaborations

She collaborates with notable colleagues, including Dong Rack Choi and De Zoysa Pathmendrra Mahanama, who contribute to her research endeavors.

Conclusion

Thi Thu Thao Nguyen's innovative work in the development of chitosan nanoparticle-based eye drops represents a significant advancement in ocular drug delivery. Her contributions are poised to enhance patient care and treatment efficacy in the field of ophthalmology.